GOVERNED TREATMENT COMPARISON
Compare weight-loss treatments without pretending one answer fits everyone
This centre compares authorised routes and their practical differences. It does not diagnose, prescribe or decide suitability. Evidence records control the facts; a qualified prescriber controls the individual medicine decision.
Written and researched by Matt O’Brien, founder of Shift Some Timber. Evidence reviewed 2026-08-26.
Mounjaro versus Wegovy
Mounjaro is weekly tirzepatide; Wegovy injection is weekly semaglutide. They target overlapping but not identical pathways and use different dose schedules. Head-to-head and separate trial evidence should be reported with population, duration and dose context.
The practical comparison includes response, side effects, dose route, availability, total service cost and whether the surrounding food, movement and follow-up plan is realistic.
Wegovy pill versus Foundayo
Both are daily GLP-1 tablets. Wegovy contains semaglutide and requires an overnight fast plus a wait before food or drink. Foundayo contains orforglipron and has greater flexibility around meals and water.
Separate trials do not create a direct winner. Routine, tolerability, medical history, expected benefit, cost and availability all require context.
Tablets versus injections
Tablets remove needles and refrigeration but require daily adherence; the Wegovy pill also creates a structured fasting routine. Weekly injections reduce dosing frequency but require storage, injection technique and sharps disposal.
Preference matters because a treatment that fits real life may be easier to use consistently. Preference cannot override safety or prescribing suitability.
Medication versus surgery
Medicines and bariatric procedures have different eligibility, evidence, reversibility, follow-up and risk profiles. Surgery is not a 'failure' and medicine is not 'cheating'. Both require informed decisions and long-term support.
People considering surgery need a specialist pathway, provider checks and a clear aftercare plan.
How this comparison is governed
Every medicine record must store its evidence source, UK authorisation status, evidence-review date and affected claims. If a dynamic fact cannot be verified, it should be withdrawn rather than guessed.
Future interactive controls may help users choose what to compare, but the output must remain decision support—not a recommendation or suitability result.
Frequently asked questions
Which weight-loss treatment is best?
There is no universal best treatment. Suitability depends on health, evidence, risks, route, routine, access and an individual assessment by an appropriately qualified professional.
Can separate trial percentages be compared directly?
Not reliably without context. Trials may use different populations, doses, durations and methods, so headline percentages should not be treated as a guaranteed league table.
Does this comparison prescribe or recommend treatment?
No. It provides general decision support. A qualified prescriber or specialist service remains responsible for an individual treatment decision.
Useful next steps
Sources you can inspect
Sources support general information, not an individual suitability decision. External organisations remain responsible for their own content.
Who wrote this?
Matt O’Brien owns the research, writing and plain-English interpretation. Matt has first-hand experience of medically supported weight management and has lost 4½ stone, but he is not presented as a doctor or prescriber.